1. Associations between IL-6 and trajectories of depressive symptoms across the life course: Evidence from ALSPAC and UK Biobank cohorts
- Author
-
Amelia J. Edmondson-Stait, Ella Davyson, Xueyi Shen, Mark James Adams, Golam M. Khandaker, Veronique E. Miron, Andrew M. McIntosh, Stephen M. Lawrie, Alex S.F. Kwong, and Heather C. Whalley
- Subjects
UK Biobank ,ALSPAC ,depression ,trajectories ,inflammation ,Psychiatry ,RC435-571 - Abstract
Abstract Background Peripheral inflammatory markers, including serum interleukin 6 (IL-6), are associated with depression, but less is known about how these markers associate with depression at different stages of the life course. Methods We examined the associations between serum IL-6 levels at baseline and subsequent depression symptom trajectories in two longitudinal cohorts: ALSPAC (age 10–28 years; N = 4,835) and UK Biobank (39–86 years; N = 39,613) using multilevel growth curve modeling. Models were adjusted for sex, BMI, and socioeconomic factors. Depressive symptoms were measured using the Short Moods and Feelings Questionnaire in ALSPAC (max time points = 11) and the Patient Health Questionnaire-2 in UK Biobank (max time points = 8). Results Higher baseline IL-6 was associated with worse depression symptom trajectories in both cohorts (largest effect size: 0.046 [ALSPAC, age 16 years]). These associations were stronger in the younger ALSPAC cohort, where additionally higher IL-6 levels at age 9 years was associated with worse depression symptoms trajectories in females compared to males. Weaker sex differences were observed in the older cohort, UK Biobank. However, statistically significant associations (pFDR
- Published
- 2025
- Full Text
- View/download PDF